Valneva's Lyme Disease Vaccine: A Glimmer of Hope Amidst Challenging Times As the world grapples with increasing infectious disease burdens, vaccine development has taken center stage.
Among the latest updates is Valneva's progress on its Lyme disease vaccine candidate, VLA15/LYME6. 3.
The company's recent earnings call provided insight into challenges and opportunities surrounding this critical area of research.